CBLL – ceribell, inc. (US:NASDAQ)
Stock Stats
News
Ceribell Receives FDA 510(k) Clearance for Use of Clarity? Algorithm for Neonates
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
CeriBell (NASDAQ:CBLL) had its price target lowered by analysts at JPMorgan Chase & Co. from $21.00 to $17.00. They now have an "overweight" rating on the stock.
CeriBell (NASDAQ:CBLL) had its price target lowered by analysts at TD Cowen from $36.00 to $20.00. They now have a "buy" rating on the stock.
Form 144 Ceribell, Inc. Filed by: Chao Xingjuan
Form 4 Ceribell, Inc. For: Dec 02 Filed by: ROBERTSON REBECCA B
Form 4 Ceribell, Inc. For: Dec 01 Filed by: Chao Xingjuan
Form 4 Ceribell, Inc. For: Dec 01 Filed by: Woo Raymond
Form 144 Ceribell, Inc. Filed by: Foehr David
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.